WASHINGTON--(BUSINESS WIRE)--Edgeworth Economics today debuts The Antitrust Prescription, the firm’s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical ...

When William Comanor was casting about for a thesis in the fall of 1961 to complete his Ph.D. in economics at Harvard University, a professor suggested he look into the pharmaceutical industry.

This course is available on the MSc Health Policy, Planning and Financing, MSc in Health, Population and Society, MSc in International Health Policy, MSc in International Health Policy (Health ...

This course is compulsory on the Executive MSc in Health Economics and Policy (LSE and Chicago). This course is not available as an outside option. The aim of this course is to introduce students to ...

How much it costs to research and develop a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter not just because of intellectual curiosity or for ...

Medical journals probably receive relatively few submissions from economists and publish even fewer. But when the economist is Joseph E. Stiglitz, winner of a Nobel Prize and a university professor at ...

This article was originally published on ETFTrends.com. The S&P 500 Health Care Index is up 18% year-to-date, an admiral though not spectacular performance. While coronavirus vaccines remain a point ...

In an analysis of patient records from a large claims database, the risk of progressing to cirrhosis, decompensated cirrhosis, liver transplant, or all-cause death increased from 10.5% after one year ...